Kedar Jambhekar
Concepts (201)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 20 | 2022 | 140 | 5.620 |
Why?
| Internship and Residency | 11 | 2022 | 502 | 3.150 |
Why?
| Pelvic Floor Disorders | 10 | 2021 | 29 | 2.900 |
Why?
| Magnetic Resonance Imaging | 25 | 2021 | 1616 | 1.880 |
Why?
| Pelvic Floor | 8 | 2021 | 47 | 1.180 |
Why?
| Image Interpretation, Computer-Assisted | 4 | 2016 | 119 | 1.130 |
Why?
| Nuclear Medicine | 2 | 2017 | 24 | 1.080 |
Why?
| Curriculum | 4 | 2014 | 432 | 0.910 |
Why?
| Internet | 3 | 2014 | 275 | 0.880 |
Why?
| Teaching | 4 | 2019 | 125 | 0.770 |
Why?
| Amyloidosis | 3 | 2016 | 85 | 0.750 |
Why?
| Education, Medical, Graduate | 4 | 2020 | 227 | 0.690 |
Why?
| Magnetic Resonance Imaging, Cine | 2 | 2016 | 65 | 0.660 |
Why?
| Computer-Assisted Instruction | 3 | 2013 | 41 | 0.640 |
Why?
| Rectum | 2 | 2019 | 52 | 0.620 |
Why?
| Rectal Neoplasms | 2 | 2019 | 51 | 0.620 |
Why?
| Career Choice | 2 | 2019 | 114 | 0.610 |
Why?
| Group Processes | 1 | 2017 | 17 | 0.590 |
Why?
| Personal Satisfaction | 1 | 2017 | 90 | 0.560 |
Why?
| Computers, Handheld | 2 | 2013 | 27 | 0.560 |
Why?
| Thoracic Diseases | 1 | 2016 | 9 | 0.560 |
Why?
| Workplace | 1 | 2017 | 98 | 0.560 |
Why?
| Lymphatic Diseases | 1 | 2016 | 24 | 0.550 |
Why?
| Fund Raising | 1 | 2015 | 3 | 0.550 |
Why?
| Humans | 47 | 2022 | 54304 | 0.540 |
Why?
| Crohn Disease | 1 | 2016 | 97 | 0.540 |
Why?
| Information Dissemination | 2 | 2014 | 104 | 0.540 |
Why?
| Sarcoidosis | 1 | 2016 | 44 | 0.530 |
Why?
| Pelvic Organ Prolapse | 3 | 2021 | 28 | 0.530 |
Why?
| Pelvic Pain | 2 | 2016 | 17 | 0.520 |
Why?
| Diagnostic Imaging | 6 | 2021 | 185 | 0.520 |
Why?
| Cooperative Behavior | 1 | 2017 | 253 | 0.510 |
Why?
| Internal Medicine | 1 | 2014 | 24 | 0.500 |
Why?
| Personnel Selection | 1 | 2014 | 28 | 0.490 |
Why?
| Marketing | 1 | 2014 | 27 | 0.490 |
Why?
| Certification | 1 | 2014 | 47 | 0.480 |
Why?
| Cardiovascular Diseases | 2 | 2017 | 472 | 0.480 |
Why?
| Sarcoma | 3 | 2020 | 72 | 0.480 |
Why?
| Heart Diseases | 1 | 2016 | 239 | 0.470 |
Why?
| Varicose Veins | 2 | 2010 | 18 | 0.470 |
Why?
| Carcinoma, Hepatocellular | 3 | 2021 | 203 | 0.460 |
Why?
| Attitude of Health Personnel | 1 | 2017 | 389 | 0.460 |
Why?
| Ovary | 2 | 2010 | 105 | 0.450 |
Why?
| Adenocarcinoma, Mucinous | 1 | 2013 | 23 | 0.450 |
Why?
| Documentation | 1 | 2013 | 32 | 0.450 |
Why?
| Information Storage and Retrieval | 1 | 2013 | 63 | 0.440 |
Why?
| Hypertension, Pulmonary | 1 | 2014 | 126 | 0.440 |
Why?
| Tomography, X-Ray Computed | 7 | 2021 | 1222 | 0.430 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 128 | 0.430 |
Why?
| Liver Neoplasms | 3 | 2021 | 352 | 0.420 |
Why?
| Education, Distance | 2 | 2022 | 39 | 0.390 |
Why?
| Colorectal Surgery | 2 | 2021 | 18 | 0.380 |
Why?
| Image Enhancement | 1 | 2010 | 56 | 0.370 |
Why?
| Magnetic Resonance Angiography | 1 | 2010 | 80 | 0.370 |
Why?
| Radiography | 2 | 2022 | 526 | 0.350 |
Why?
| Soft Tissue Neoplasms | 2 | 2020 | 65 | 0.340 |
Why?
| Arkansas | 5 | 2015 | 2097 | 0.340 |
Why?
| Algorithms | 5 | 2021 | 697 | 0.290 |
Why?
| United States | 11 | 2022 | 5204 | 0.260 |
Why?
| Female | 18 | 2021 | 28457 | 0.260 |
Why?
| Contrast Media | 3 | 2021 | 221 | 0.260 |
Why?
| Defecography | 5 | 2021 | 16 | 0.250 |
Why?
| Muscular Diseases | 2 | 2014 | 65 | 0.240 |
Why?
| Joint Diseases | 2 | 2014 | 43 | 0.230 |
Why?
| Physical Examination | 2 | 2014 | 99 | 0.230 |
Why?
| Societies, Medical | 2 | 2021 | 197 | 0.220 |
Why?
| Positron-Emission Tomography | 2 | 2016 | 323 | 0.220 |
Why?
| User-Computer Interface | 2 | 2013 | 92 | 0.220 |
Why?
| Fellowships and Scholarships | 2 | 2020 | 118 | 0.210 |
Why?
| Societies, Scientific | 1 | 2021 | 15 | 0.210 |
Why?
| Software | 2 | 2016 | 297 | 0.200 |
Why?
| Education, Medical, Undergraduate | 1 | 2022 | 84 | 0.200 |
Why?
| Suburethral Slings | 1 | 2021 | 12 | 0.200 |
Why?
| Retrospective Studies | 5 | 2022 | 6462 | 0.190 |
Why?
| Urinary Incontinence, Stress | 1 | 2021 | 31 | 0.190 |
Why?
| Diagnosis, Differential | 4 | 2018 | 1143 | 0.180 |
Why?
| Anatomy, Regional | 1 | 2019 | 2 | 0.180 |
Why?
| Mesocolon | 1 | 2019 | 2 | 0.180 |
Why?
| Students, Medical | 1 | 2022 | 178 | 0.170 |
Why?
| Male | 13 | 2021 | 27335 | 0.170 |
Why?
| North America | 1 | 2019 | 72 | 0.170 |
Why?
| Embolization, Therapeutic | 3 | 2010 | 98 | 0.160 |
Why?
| Biopsy | 2 | 2017 | 693 | 0.150 |
Why?
| Tissue Transplantation | 1 | 2017 | 11 | 0.150 |
Why?
| Muscle Neoplasms | 1 | 2017 | 21 | 0.150 |
Why?
| Neurilemmoma | 1 | 2017 | 28 | 0.150 |
Why?
| Diabetes Complications | 2 | 2014 | 123 | 0.150 |
Why?
| Consensus | 3 | 2021 | 156 | 0.140 |
Why?
| Medicine | 1 | 2017 | 58 | 0.140 |
Why?
| Middle Aged | 10 | 2021 | 13076 | 0.140 |
Why?
| Free Tissue Flaps | 1 | 2017 | 56 | 0.140 |
Why?
| Sensitivity and Specificity | 3 | 2013 | 922 | 0.140 |
Why?
| Gift Giving | 1 | 2015 | 5 | 0.140 |
Why?
| Mesenteric Veins | 2 | 2019 | 14 | 0.130 |
Why?
| Diagnosis-Related Groups | 1 | 2014 | 23 | 0.130 |
Why?
| Infarction | 1 | 2014 | 15 | 0.130 |
Why?
| Evidence-Based Medicine | 1 | 2016 | 275 | 0.120 |
Why?
| Program Development | 1 | 2015 | 198 | 0.120 |
Why?
| Wrist Joint | 1 | 2014 | 11 | 0.120 |
Why?
| Aged | 6 | 2021 | 10054 | 0.120 |
Why?
| After-Hours Care | 1 | 2014 | 11 | 0.120 |
Why?
| Ankle Joint | 1 | 2014 | 28 | 0.120 |
Why?
| Patient Handoff | 1 | 2014 | 15 | 0.120 |
Why?
| Systole | 1 | 2014 | 80 | 0.120 |
Why?
| Program Evaluation | 1 | 2015 | 379 | 0.120 |
Why?
| Hip Joint | 1 | 2014 | 66 | 0.120 |
Why?
| Neoplasm Staging | 2 | 2013 | 805 | 0.120 |
Why?
| Elbow Joint | 1 | 2014 | 39 | 0.120 |
Why?
| Interviews as Topic | 1 | 2014 | 314 | 0.110 |
Why?
| Shoulder Joint | 1 | 2014 | 71 | 0.110 |
Why?
| Bone Marrow Transplantation | 1 | 2014 | 149 | 0.110 |
Why?
| Case-Control Studies | 1 | 2016 | 1229 | 0.110 |
Why?
| Knee Joint | 1 | 2014 | 175 | 0.110 |
Why?
| Syndrome | 2 | 2010 | 253 | 0.110 |
Why?
| Reproducibility of Results | 2 | 2013 | 1294 | 0.100 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2014 | 202 | 0.100 |
Why?
| Early Detection of Cancer | 1 | 2013 | 164 | 0.100 |
Why?
| Defecation | 2 | 2021 | 8 | 0.100 |
Why?
| Anatomic Landmarks | 2 | 2021 | 23 | 0.100 |
Why?
| Adult | 6 | 2021 | 14189 | 0.100 |
Why?
| Acetylcysteine | 1 | 2011 | 118 | 0.100 |
Why?
| Liver Failure, Acute | 1 | 2011 | 64 | 0.100 |
Why?
| Multiple Myeloma | 2 | 2017 | 3049 | 0.100 |
Why?
| Cardiomyopathies | 1 | 2012 | 131 | 0.100 |
Why?
| Practice Guidelines as Topic | 3 | 2020 | 487 | 0.090 |
Why?
| Phlebography | 1 | 2010 | 70 | 0.090 |
Why?
| Mass Screening | 1 | 2013 | 366 | 0.090 |
Why?
| Endosonography | 1 | 2010 | 96 | 0.090 |
Why?
| Pelvis | 2 | 2020 | 77 | 0.090 |
Why?
| Hematuria | 1 | 2009 | 24 | 0.090 |
Why?
| Abdomen | 2 | 2020 | 84 | 0.090 |
Why?
| Myocardium | 1 | 2012 | 443 | 0.090 |
Why?
| Acetaminophen | 1 | 2011 | 350 | 0.080 |
Why?
| Prognosis | 1 | 2013 | 2126 | 0.080 |
Why?
| Lung Neoplasms | 1 | 2013 | 643 | 0.070 |
Why?
| Liver Cirrhosis | 1 | 2009 | 218 | 0.070 |
Why?
| Aged, 80 and over | 2 | 2014 | 3430 | 0.070 |
Why?
| Dyskinesias | 1 | 2006 | 4 | 0.070 |
Why?
| Treatment Outcome | 3 | 2014 | 5609 | 0.070 |
Why?
| Pandemics | 2 | 2022 | 593 | 0.070 |
Why?
| Brain Diseases | 1 | 2006 | 88 | 0.070 |
Why?
| Follow-Up Studies | 1 | 2010 | 2389 | 0.060 |
Why?
| Arthralgia | 2 | 2014 | 49 | 0.060 |
Why?
| Spinal Neoplasms | 1 | 2003 | 32 | 0.060 |
Why?
| Neurosurgical Procedures | 1 | 2003 | 121 | 0.050 |
Why?
| Preoperative Care | 1 | 2003 | 184 | 0.050 |
Why?
| Interdisciplinary Communication | 1 | 2021 | 64 | 0.050 |
Why?
| Radiography, Abdominal | 1 | 2021 | 29 | 0.050 |
Why?
| Surgical Mesh | 1 | 2021 | 18 | 0.050 |
Why?
| Colon | 1 | 2021 | 111 | 0.050 |
Why?
| Foreign Medical Graduates | 1 | 2020 | 7 | 0.050 |
Why?
| Schools, Medical | 1 | 2020 | 82 | 0.050 |
Why?
| Educational Measurement | 1 | 2022 | 232 | 0.050 |
Why?
| Mesenteric Artery, Inferior | 1 | 2019 | 3 | 0.050 |
Why?
| Accreditation | 1 | 2020 | 73 | 0.050 |
Why?
| Lymphatic System | 1 | 2019 | 15 | 0.050 |
Why?
| Splanchnic Circulation | 1 | 2019 | 43 | 0.040 |
Why?
| Personnel Management | 1 | 2019 | 21 | 0.040 |
Why?
| Organizational Culture | 1 | 2019 | 46 | 0.040 |
Why?
| Ultrasonography | 1 | 2021 | 486 | 0.040 |
Why?
| Patient Education as Topic | 1 | 2021 | 310 | 0.040 |
Why?
| Myoblasts, Skeletal | 1 | 2017 | 11 | 0.040 |
Why?
| Fibula | 1 | 2017 | 23 | 0.040 |
Why?
| Radiotherapy, Adjuvant | 1 | 2017 | 66 | 0.040 |
Why?
| Soft Tissue Injuries | 1 | 2017 | 22 | 0.040 |
Why?
| Tibial Fractures | 1 | 2017 | 34 | 0.040 |
Why?
| Risk Factors | 2 | 2017 | 3934 | 0.040 |
Why?
| Cell Transformation, Neoplastic | 1 | 2017 | 200 | 0.030 |
Why?
| Heart | 1 | 2017 | 361 | 0.030 |
Why?
| Echocardiography | 1 | 2017 | 392 | 0.030 |
Why?
| Thigh | 1 | 2014 | 40 | 0.030 |
Why?
| Quality of Life | 1 | 2021 | 922 | 0.030 |
Why?
| Necrosis | 1 | 2014 | 208 | 0.030 |
Why?
| Cell Differentiation | 1 | 2017 | 720 | 0.030 |
Why?
| Personnel Staffing and Scheduling | 1 | 2014 | 29 | 0.030 |
Why?
| False Positive Reactions | 1 | 2013 | 68 | 0.030 |
Why?
| Tumor Burden | 1 | 2013 | 141 | 0.030 |
Why?
| Ventricular Dysfunction, Left | 1 | 2014 | 99 | 0.030 |
Why?
| Transplantation, Autologous | 1 | 2014 | 485 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2013 | 291 | 0.030 |
Why?
| Expectorants | 1 | 2011 | 14 | 0.030 |
Why?
| Antidotes | 1 | 2011 | 33 | 0.030 |
Why?
| Patient Selection | 1 | 2013 | 284 | 0.030 |
Why?
| Statistics as Topic | 1 | 2011 | 100 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2012 | 318 | 0.020 |
Why?
| Washington | 1 | 2010 | 46 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2017 | 847 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2013 | 580 | 0.020 |
Why?
| Analgesics, Non-Narcotic | 1 | 2011 | 140 | 0.020 |
Why?
| Smoking | 1 | 2013 | 552 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2012 | 1044 | 0.020 |
Why?
| Fatty Liver | 1 | 2009 | 129 | 0.020 |
Why?
| Chorea | 1 | 2006 | 12 | 0.020 |
Why?
| Hyperglycemia | 1 | 2006 | 83 | 0.020 |
Why?
| Fatal Outcome | 1 | 2006 | 225 | 0.020 |
Why?
| Time Factors | 1 | 2012 | 3207 | 0.020 |
Why?
| Arteriovenous Fistula | 1 | 2003 | 26 | 0.010 |
Why?
| Angiography | 1 | 2003 | 148 | 0.010 |
Why?
| Survival Analysis | 1 | 2003 | 736 | 0.010 |
Why?
| Mice | 1 | 2011 | 6428 | 0.010 |
Why?
| Animals | 1 | 2011 | 14402 | 0.010 |
Why?
|
|
Jambhekar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|